China Traditional Chinese Medicine Holdings Co (STU:WSG) Total Stockholders Equity : €2,781 Mil (As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is China Traditional Chinese Medicine Holdings Co Total Stockholders Equity?

China Traditional Chinese Medicine Holdings Co's Total Stockholders Equity for the quarter that ended in Dec. 2024 was €2,781 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. China Traditional Chinese Medicine Holdings Co's Book Value per Share for the quarter that ended in Dec. 2024 was €0.55. The ratio of a company's debt over equity can be used to measure how leveraged this company is. China Traditional Chinese Medicine Holdings Co's Debt-to-Equity for the quarter that ended in Dec. 2024 was 0.19.

China Traditional Chinese Medicine Holdings Co Total Stockholders Equity Historical Data

The historical data trend for China Traditional Chinese Medicine Holdings Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Traditional Chinese Medicine Holdings Co Total Stockholders Equity Chart

China Traditional Chinese Medicine Holdings Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Stockholders Equity

Get a 7-Day Free Trial

2,270.68

2,740.03

2,730.86

2,717.55

2,781.27

China Traditional Chinese Medicine Holdings Co Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Total Stockholders Equity	Get a 7-Day Free Trial															2,730.86	2,643.81	2,717.55	2,736.67	2,781.27

China Traditional Chinese Medicine Holdings Co (STU:WSG) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

China Traditional Chinese Medicine Holdings Co's Book Value per Share for the quarter that ended in Dec. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(2781.273	-	0)	/	5035.801
	=	0.55

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

China Traditional Chinese Medicine Holdings Co's Debt-to-Equity for the quarter that ended in Dec. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(278.591	+	248.135)	/	2781.273
	=	0.19

China Traditional Chinese Medicine Holdings Co Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of China Traditional Chinese Medicine Holdings Co's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

China Traditional Chinese Medicine Holdings Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Traditional Chinese Medicine Holdings Co Ltd (STU:WSG) » Definitions » Total Stockholders Equity

Traded in Other Exchanges

00570:Hong Kong

Address

288 Hennessy Road, Room 1601, Emperor Group Centre, Wanchai, Hong Kong, HKG

Website

https://www.china-tcm.com.cn

China Traditional Chinese Medicine Holdings Co Ltd is engaged in the Chinese healthcare sector. The company functions through four segments: Yi Fang, Tian Jiang, Tong Ji Tang, and Medi-World. It generates maximum revenue from the Yifang segment which mainly engages in the manufacture and sales of concentrated TCM granules (CTCMG), TCM healthcare products, and TCM decoction pieces under the Yi Fang brand. The majority of the revenue of the Yi Fang segment is derived from the sales of CTCMG. Geographically, it derives a majority of its revenue from Mainland China, and also has its presence in Hong Kong and Other countries.